| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nektar Therapeutics (NKTR) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. NKTR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 75.9K | $4.92M | - | |
| Other | 21.6K | $1.40M | - | |
| Other | 15.4K | $1.00M | -5,538 | |
| Dir | 8.0K | $518.7K | - | |
| Dir | 8.0K | $518.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 5, 2017 | Doberstein Stephen K | SVP &Chief Scientific Officer | Sale+OE | 43,677 | $24.97 | $1,090,614.69 | -58.4% | |
| Oct 5, 2017 | Hora Maninder | SVP Pharma Dev &Mfg Ops | Sale+OE | 7,583 | $25.00 | $189,575.00 | -11.5% | |
| Oct 2, 2017 | Labrucherie Gil M84 | SVP &Chief Financial Officer | Sale+OE | 120,000 | $24.45 | $2,934,000.00 | -65.4% | |
| Oct 2, 2017 | Gergel Ivan P. | SVP &Chief Medical Officer | Sale+OE | 100,000 | $24.14 | $2,413,639.68 | -54.6% | |
| Sep 22, 2017 | Lingnau Lutz | Director | Sell | 5,000 | $21.97 | $109,850.00 | -15.4% | |
| Sep 22, 2017 | Kuebler Christopher A58 | Director | Sell | 4,000 | $21.86 | $87,440.00 | -9.0% | |
| Sep 21, 2017 | Chess Robert84 | Director | Sell | 6,400 | $21.72 | $139,008.00 | -2.3% | |
| Sep 6, 2017 | Robin Howard W58 | President &CEO | Sale+OE | 83,333 | $21.54 | $1,794,992.82 | -35.3% | |
| Aug 16, 2017 | Thomsen Jillian B.86 | SVP &Chief Accounting Officer | Sell | 2,648 | $19.32 | $51,159.36 | -5.0% | |
| Aug 16, 2017 | Robin Howard W58 | President &CEO | Sale+OE | 91,714 | $19.26 | $1,766,081.10 | -23.1% |